The healthcare diagnostics provider reported robust 9M 2025 results, with revenue up 41% and margins expanding significantly. The company's performance highlights its operational efficiency and growth potential.
The healthcare provider announces upcoming Q3 2025 results and an investor call, without providing any additional details.
The diagnostics services provider reported impressive H1 2025 results, with 42% revenue growth and significant margin improvements across all operations. Strong performance was seen in both established and newer markets.
The healthcare company will publish its Q2 2025 results on September 2nd and host an analyst call on September 15th.
The healthcare diagnostics provider has acquired a radiology and radiotherapy facility in Cairo, Egypt, expanding its radiology portfolio in the country.
The diagnostics provider reported a 35% jump in revenue and substantial margin expansion in Q1 2025, signaling a strong start to the year.
The healthcare provider offers a general update on its operations across the Middle East and Africa.
The healthcare diagnostics company has published its 2024 annual report and announced the date for its upcoming annual general meeting.
The diagnostics services provider reported a 39% revenue surge and 115% profit increase, driven by higher test volumes and improved margins. Despite strong performance, the company faces challenges in certain markets and economic uncertainties.
The healthcare company provides a general update on its operations in the Middle East and Africa.